$NVAX Company News Novavax Inc. up 16% in

New Post Public Reply Private Reply Replies (0) Message Board

Dec 3, 2013 at 4:52 PM

$NVAX Company News

Novavax Inc. up 16% in premarket
6:52 a.m. Oct. 25, 2012
- Steve Gelsi

Novavax gains 11% on flu vaccine update
11:29 a.m. July 25, 2012
- Val Brickates Kennedy

Tuesday’s biggest gainers and decliners
6:42 p.m. March 1, 2011
- Kate Gibson

Novavax grabs drug-stock spotlight
12:49 p.m. March 1, 2011
- Val Brickates Kennedy

Novavax shares rally on government contract
10:03 a.m. March 1, 2011
- Val Brickates Kennedy

Tuesday's biggest gaining and declining stocks
3:38 p.m. July 27, 2010
- MarketWatch

Baxter, Affymetrix lead drug stocks lower
1:05 p.m. April 22, 2010
- Val Brickates Kennedy

Wednesday's biggest gaining and declining stocks
3:56 p.m. March 24, 2010
- MarketWatch

Poniard, Genzyme lead drug stocks south
10:10 a.m. March 24, 2010
- Val Brickates Kennedy

Drug stocks turn higher; Shire, XenoPort gain
12:59 p.m. Feb. 19, 2010
- Val Brickates Kennedy

Monday's biggest gaining and declining stocks
5:16 p.m. Feb. 8, 2010
- MarketWatch

Drug stocks turn higher; Cell Therapeutics tumbles
1:14 p.m. Feb. 8, 2010
- Val Brickates Kennedy

Novavax shares down 9%
9:37 a.m. Feb. 8, 2010
- Nick Godt

Novavax, Rovi end flu-vaccine-development plan
2:27 a.m. Feb. 8, 2010
- Robert Daniel

Novavax raises $21 million in stock offering
9:10 a.m. Dec. 9, 2009
- Val Brickates Kennedy

Dyax, Santarus, CytRx soar; Hemispherx craters
11:38 a.m. Dec. 2, 2009
- Val Brickates Kennedy

Drug stocks split; Theravance slides on setback
1:22 p.m. Nov. 30, 2009
- Val Brickates Kennedy

Novavax sees Phase III vaccine testing in 2010
9:32 a.m. Nov. 30, 2009
- Val Brickates Kennedy

Inovio, Merck gain; Novavax falls
4:26 p.m. Nov. 20, 2009
- Val Brickates Kennedy

Friday's biggest gaining and declining stocks
4:25 p.m. Nov. 20, 2009
- MarketWatch

New Top Stocks to Buy Under $10 with Big Upside
7:16 a.m. Nov. 18, 2013
- 247WallSt.com

Breakthrough In Virus Vaccination Can Instigate A Super Run Of Novavax

12:41 p.m. Nov. 17, 2013
- Seeking Alpha

Benzinga's Top #PreMarket Gainers

7:11 a.m. Nov. 14, 2013
- benzinga.com

Novavax Shares Edge Higher as the New England Journal of Medicine Has Published Data on Co.'s Bird Flu Vaccine

4:26 p.m. Nov. 13, 2013
- benzinga.com

Novavax Management Discusses Q3 2013 Results - Earnings Call Transcript

7:20 p.m. Nov. 7, 2013
- Seeking Alpha

Two Speculative Biotech Stocks

11:00 a.m. Oct. 31, 2013
- RealMoney.com

Buy Novavax On Vaccine Market Growth

2:31 p.m. Oct. 30, 2013
- Seeking Alpha

First Week Of NVAX December 21st Options Trading

10:54 a.m. Oct. 23, 2013
- TheStreet.com

Wall Street Analysts’ Top Stocks to Buy Trading Under $10
7:35 a.m. Sept. 30, 2013
- 247WallSt.com

John McCamant Scans Under The Radar For Promising Biotechs

9:11 a.m. Sept. 27, 2013
- Seeking Alpha

NVAX: Insiders Vs. Shorts

2:48 p.m. Sept. 26, 2013
- TheStreet.com

First Week Of November 16th Options Trading For Novavax (NVAX)

2:05 p.m. Sept. 26, 2013
- TheStreet.com

Novavax: A Vaccine Company On The Rise

2:31 p.m. Sept. 25, 2013
- Seeking Alpha

Novavax: Why Investors Are Excited Now

12:22 p.m. Sept. 25, 2013
- Seeking Alpha

Novavax, Inc. - Shareholder/Analyst Call

4:10 p.m. Sept. 24, 2013
- Seeking Alpha

Novavax's CEO Hosts Analyst and Investor Update Conference (Transcript)

4:10 p.m. Sept. 24, 2013
- Seeking Alpha

Novavax to Initiate Seasonal and Pandemic Influenza Trials in Collaboration With BARDA

7:03 a.m. Sept. 24, 2013
- benzinga.com

Novavax Prices Public Offering of Common Stock at $3.14 per Share

7:02 a.m. Sept. 24, 2013
- benzinga.com

3 Stocks Under $5 With Triple-Digit Upside

4:04 p.m. Sept. 20, 2013
- Seeking Alpha

3 Stocks Under $5 With Huge Upside

8:30 a.m. Sept. 20, 2013
- streetauthority.com

Companies Report Corporate Growth and Positive Clinical Data - Research Report on Humana, Molina Healthcare, Novavax, Kindred Healthcare, and Repligen
8:00 a.m. Nov. 27, 2013
- PR Newswire

Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp.
8:00 a.m. Nov. 27, 2013
- PR Newswire

Novavax to Present at the 25th Annual Piper Jaffray Healthcare Conference
4:05 p.m. Nov. 26, 2013
- GlobeNewswire

Financial Reports, Partnerships, Settlement Agreements, and Strategic Acquisitions - Research Report on Mallinckrodt, WellCare, Mindray, Oxygen Biotherapeutics, and Novavax
8:00 a.m. Nov. 19, 2013
- PR Newswire

New England Journal of Medicine Publishes Positive Data From Clinical Trial of Novavax' Vaccine Against H7N9 Avian Flu
5:01 p.m. Nov. 13, 2013
- GlobeNewswire

Novavax Reports Third-Quarter 2013 Financial Results
4:10 p.m. Nov. 7, 2013
- GlobeNewswire

ACAD, CRTX, MACK and NVAX added to NASDAQ Healthcare Stock Watch List at EPR
9:28 a.m. Nov. 7, 2013
- ACCESSWIRE

Clinical Trials Results, Financial Results, and Upcoming Earnings Releases- Research Report on Teleflex, Oxygen Biotherapeutics, Novavax, Prana Biotechnology and Hanger Orthopedic
8:00 a.m. Nov. 4, 2013
- PR Newswire

Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc.
1:30 p.m. Nov. 1, 2013
- PR Newswire

Novavax to Report Third Quarter 2013 Financial Results on November 7, 2013
4:58 p.m. Oct. 30, 2013
- GlobeNewswire

Pre-Market Review: MannKind Corp., Galena Biopharma Inc., Ariad Pharmaceuticals Inc., and Novavax Inc.
3:40 p.m. Oct. 10, 2013
- PR Newswire

Product Development Strategies, FDA Approval, Incremental Agreement, New Clinical Studies, and Other Announcements - Research Report on Amarin, Discovery Labs, Auxilium, Novavax, and Accuray
8:00 a.m. Oct. 9, 2013
- PR Newswire

Novavax Initiates Dose-Confirmatory Phase 2 Clinical Trial of its RSV Vaccine Candidate
4:35 p.m. Oct. 7, 2013
- GlobeNewswire

Novavax Completes $100 Million Public Offering of Common Stock
11:29 a.m. Sept. 27, 2013
- GlobeNewswire

Beginning New Clinical Trials, Innovation Recognitions, Expansion in Patent Portfolios, Product Distributions and Offerings - Research Report on Allscripts, Novavax, Amarin, Acura, and Catalyst
8:00 a.m. Sept. 27, 2013
- PR Newswire

Novavax Prices Public Offering of Common Stock
8:06 a.m. Sept. 24, 2013
- GlobeNewswire

Novavax to Initiate Seasonal and Pandemic Influenza Trials in Collaboration With BARDA
8:00 a.m. Sept. 24, 2013
- GlobeNewswire

Novavax to Host an Analyst and Investor Update Call With Webcast
6:25 p.m. Sept. 17, 2013
- GlobeNewswire

Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX
9:02 a.m. Sept. 16, 2013
- ACCESSWIRE

Novavax Highlights Positive Results From Partner's Clinical Trial of Vaccine Using Matrix-M(TM)
9:03 a.m. Sept. 13, 2013
- GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navimow Powers TOP 14 with Tech: A Winning Play

A Technological Leap for French Rugby Innovation and precision in partnerships—those words don't usually pop up together when chatting about a rugby league. But here we are, discussing the TOP 14, the elite French rugby championship, pairing up with Segway Navimow. This brand, under the umbrella of Ninebot Limited (689009.SH), is stepping into the world of sports for...

Tech Breakthroughs in Cancer and Space Energy Aired

Science and Technology at the Forefront Saturday nights usually have folks kicking back with some reality shows or maybe cheering on their favorite sports team. But this September 12, savvy viewers have a chance to dive deep into the guts of cutting-edge science and tech on Bloomberg Television. We're talking about 'Advancements with Ted Danson'—where science isn’t...

Consumer365 Highlights Happy Head's Personalized Hair Solutions

Tailored Hair Loss Solutions by Happy Head Imagine trying to fit a square peg in a round hole. That's what one-size-fits-all approaches often feel like in the world of hair loss treatments. Happy Head, recognized by Consumer365, takes that notion and turns it on its head, offering personalized minoxidil formulations for women. The key word here is personalized. More Than...

Huion Kamvas Pad 12: A Creative Power Tool

The Kamvas Pad 12 Hits the Market In a crowded tablet market that's fierce with innovation, Huion tossed their latest tool into the ring—the Kamvas Pad 12. Now, anyone who’s been watching the digital art scene won't be surprised that Huion, with its decade and a half of digital prowess, is pulling another tablet trick out of its hat. Key Features and Innovations If...

Hyosung Targets U.S. AI Power Market with Advanced SST

Hyosung's Game-Changing Move in the AI Power Sector Guess what? The AI era's heating up, and it's dragging the power sector along for a wild ride. Hyosung Chairman Hyun-Joon Cho peered into that future and decided it's all-in time for the U.S. power market. With AI and data centers cranking up power demands like never before, those rickety old wires need an upgrade fast....

Sony Expands Versatile Wireless Headphone Lineup: 2026

Renewed Focus on Sound: Sony's Latest Headphones Sony's dipping into the headphone market this time with a splash of style and sound signature updates. We've got the WH-1000XM4C, a next-gen version of the top-dog noise-cancelling cans, that are gonna catch the eye of every audiophile and traveler out there. WH-1000XM4C: The Flagship gets a Lift What they're offering is...

Nutromics Welcomes Plaxco: Strategic Tech Leap Forward

Professor Plaxco’s Dynamic Role at Nutromics Some folks start their day with breakfast and coffee, but Nutromics is grabbing headlines by introducing Professor Kevin Plaxco as the new Chief Scientific Officer. This strategic shift, made public on September 7, 2026, signals Nutromics’ ambition to amplify its DNA-based sensing footprint. As they gear up to launch their...

Nuix Leverages AI for Transformative Legal Review

Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...

Papa John's Faces Investor Lawsuit: Class Action Looms

Papa John's in Hot Water Again? Look, just when you think the pizza game is all dough and cheesy goodness, along comes a legal scuffle to toss our assumptions. Bronstein, Gewirtz & Grossman, LLC has slapped a class action lawsuit against Papa John's International, Inc. (NASDAQ: PZZA), claiming the company and some of its higher-ups haven't been playing fair with the...

XiamenAir Takes Off with Fujian-London Link

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...